PharmEasy Boosts Its Telehealth Consultation Offerings

1. Expansion of Services

PharmEasy has strengthened its online doctor consultation segment.
The platform is enhancing access to virtual healthcare services across India.

2. Wider Medical Specialties

Consultations are now available across multiple specialties.
Patients can connect with certified doctors through the app or website.

3. 24/7 Accessibility

Round-the-clock doctor availability improves convenience for users.
Enables faster medical advice without the need for physical visits.

4. Integrated Healthcare Ecosystem

Online consultations are integrated with diagnostics and medicine delivery.
Users can consult a doctor, get prescriptions, and order medicines within the same platform.

5. Focus on Affordability

The service aims to provide cost-effective healthcare access.
Reduces travel time and associated expenses for patients.

6. Digital Health Push

Strengthens PharmEasy’s position in India’s growing telemedicine market.
Aligns with the broader shift toward digital-first healthcare solutions.

Source: https://indiamedtoday.com/pharmeasy-expands-online-doctor-consultations/

Comments

Trade Unlisted (TU) is not a stock exchange or an online platform for buying or selling unlisted shares, luxury assets, or real estate. It is not regulated by SEBI, IRDAI, RERA, or any other authority. Our focus is to provide information on unlisted startup companies, luxury assets, and real estate. We do not offer investment advice, guarantees, or warranties regarding any asset class. Investing in unlisted equities or alternative assets is high-risk and suitable only for accredited high-net-worth individuals (HNIs) with a long-term investment horizon. There is a possibility of capital loss, and investors should conduct their own due diligence and consult financial advisors before making decisions.The information on this website is for general informational purposes only and should not be construed as personalized investment advice or a recommendation to buy or sell any asset class. Market trends and data interpretations are illustrative and may not reflect actual future performance. TU is neither a stock exchange nor intends to be recognized as one under the Securities Contracts (Regulation) Act, 1956. We are not authorized to solicit investments, and the securities or asset classes discussed are not traded on regulated exchanges. While we strive for accuracy and timeliness, we make no representations or warranties regarding the completeness or reliability of the information. Any reliance on such information is at the user's own risk, and TU does not accept liability for decisions made based on this website.